T. Rowe Price Associates’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $277M | Buy |
|
|||||
|
2025
Q2 | $267M | Sell |
|
|||||
|
2025
Q1 | $612M | Buy |
|
|||||
|
2024
Q4 | $523M | Buy |
|
|||||
|
2024
Q3 | $332M | Buy |
|
|||||
|
2024
Q2 | $90.3M | Buy |
|
|||||
|
2024
Q1 | $64.4M | Sell |
|
|||||
|
2023
Q4 | $67.5M | Buy |
|
|||||
|
2023
Q3 | $72.1M | Sell |
|
|||||
|
2023
Q2 | $74.3M | Sell |
|
|||||
|
2023
Q1 | $111M | Sell |
|
|||||
|
2022
Q4 | $139M | Sell |
|
|||||
|
2022
Q3 | $472M | Sell |
|
|||||
|
2022
Q2 | $863M | Buy |
|
|||||
|
2022
Q1 | $337M | Buy |
|
|||||
|
2021
Q4 | $308M | Buy |
|
|||||
|
2021
Q3 | $271M | Buy |
|
|||||
|
2021
Q2 | $231M | Sell |
|
|||||
|
2021
Q1 | $217M | Buy |
|
|||||
|
2020
Q4 | $146M | Buy |
|
|||||
|
2020
Q3 | $71M | Buy |
|
|||||
|
2020
Q2 | $63.8M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $268K | Buy |
|